Saugatuck Therapeutics Overview

  • Status
  • Private
  • Latest Deal Type
  • Joint Venture
  • Financing Rounds
  • 1

Saugatuck Therapeutics General Information

Description

Developer of early-stage biotechnology intended to focus on the development of co-formulation of different types of immune-based therapeutics in a novel delivery system. The company has an exclusive licensee of NLG technology for certain immuno-oncology applications which thereby allows different combination therapies to be encapsulated in a single nanomedicine, and delivered selectively to the tumor microenvironment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 47 Avenue Road
  • Toronto, Ontario M5R 2G3
  • Canada
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Saugatuck Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Saugatuck Therapeutics‘s full profile, request access.

Request a free trial

Saugatuck Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Ian Walters MD Chairman & Managing Director
To view Saugatuck Therapeutics’s complete executive team members history, request access »

Saugatuck Therapeutics Board Members (1)

Name Representing Role Since
000 0000000 00 Self Chairman & Managing Director 000 0000
To view Saugatuck Therapeutics’s complete board members history, request access »

Saugatuck Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Saugatuck Therapeutics‘s full profile, request access.

Request a free trial